Collectively, these findings suggest that FGA can be classified as a tissue-specific serum protein and may serve as a blood-based biomarker for predicting the response of patients with lung ADC to treatment with platinum and antimetabolite drugs. The gene discussed is FGA; the disease is AIDS dementia complex.